Kirsten Marriner Clorox CO (CLX) insider trading activity

Kirsten Marriner is EVP - Chief People Officer of CLOROX CO . Currently has a direct ownership of 34,532 shares of CLX, which is worth approximately $5.68 Million. The most recent transaction as insider was on Nov 15, 2024, when has been sold 640 shares (Common Stock) at a price of $167.64 per share, resulting in proceeds of $107,289. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 34.5K

10.69% 3M change

32.65% 12M change

Total Value Held $5.68 Million

Kirsten Marriner Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 15 2024	SELL Payment of exercise price or tax liability	$107,289 $167.64 p/Share	640 Reduced 1.82%	34,532 Common Stock
Oct 04 2024	SELL Payment of exercise price or tax liability	$477,924 $161.57 p/Share	2,958 Reduced 7.76%	35,172 Common Stock
Oct 04 2024	BUY Grant, award, or other acquisition	$1,114,509 $161.57 p/Share	6,898 Added 15.32%	38,130 Common Stock
Sep 17 2024	BUY Grant, award, or other acquisition	$859,846 $164.69 p/Share	5,221 Added 14.34%	31,198 Common Stock
Sep 13 2024	SELL Payment of exercise price or tax liability	$14,798 $166.27 p/Share	89 Reduced 0.34%	25,977 Common Stock
Nov 15 2023	BUY Grant, award, or other acquisition	$799,905 $138.01 p/Share	5,796 Added 18.21%	26,033 Common Stock
Oct 05 2023	SELL Payment of exercise price or tax liability	$36,729 $124.93 p/Share	294 Reduced 1.43%	20,237 Common Stock
Sep 13 2023	SELL Payment of exercise price or tax liability	$167,536 $147.35 p/Share	1,137 Reduced 5.26%	20,471 Common Stock
Sep 13 2023	BUY Grant, award, or other acquisition	$465,036 $147.35 p/Share	3,156 Added 12.74%	21,608 Common Stock
Oct 05 2022	SELL Payment of exercise price or tax liability	$18,042 $131.69 p/Share	137 Reduced 0.74%	18,452 Common Stock
Sep 20 2022	BUY Grant, award, or other acquisition	$299,980 $141.3 p/Share	2,123 Added 10.25%	18,580 Common Stock
Sep 13 2022	SELL Payment of exercise price or tax liability	$150,336 $144.0 p/Share	1,044 Reduced 5.97%	16,457 Common Stock
Sep 13 2022	BUY Grant, award, or other acquisition	$391,248 $144.0 p/Share	2,717 Added 13.44%	17,501 Common Stock
Sep 22 2021	SELL Payment of exercise price or tax liability	$15,895 $162.19 p/Share	98 Reduced 0.67%	14,608 Common Stock
Sep 21 2021	BUY Grant, award, or other acquisition	$259,903 $163.77 p/Share	1,587 Added 9.74%	14,702 Common Stock
Aug 19 2021	SELL Payment of exercise price or tax liability	$155,872 $171.1 p/Share	911 Reduced 6.5%	13,115 Common Stock
Aug 19 2021	BUY Grant, award, or other acquisition	$450,335 $171.1 p/Share	2,632 Added 15.8%	14,026 Common Stock
Nov 18 2020	SELL Open market or private sale	$13,063,260 $210.0 p/Share	62,206 Reduced 84.67%	11,267 Common Stock
Nov 18 2020	BUY Exercise of conversion of derivative security	$8,380,049 $128.2 p/Share	65,367 Added 47.08%	73,473 Common Stock

Also insider at

ZVO

Zovio Inc Consumer Defensive

Director